Echo Pharmaceuticals is a company specialised in cannabinoids aiming to meet patient needs in a wide range of therapeutic areas. Our clinical development programs focus on MS, Epilepsy, Nausea and Pain, with our leading products Namisol® (oral tablet containing pure THC), and Arvisol® (oral tablet containing CBD). Our drug delivery technologies, including the novel lipophilic compound delivery technology, Alitra™ can be applied to any cannabinoid.

Echo News

05/01/16 Echo is visiting JPM Healthcare Conference 2016 in San Francisco from the 11th till 14th of January Echo Pharmaceuticals is visiting the JP Morgan 34th Healthc... more

19/08/15 Clinical data reassures safety and tolerability of THC-based medicine Namisol® Clinical data reassures safety and tolerability of THC-ba... more

27/07/15 Improved uptake of cannabinoid based medicine ... more

In the Spotlight


NEW - Job Opportunities / Openstaande Vacatures  

Clinical Research Manager